Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored

Clinical and Vaccine Immunology

Volumn 14, Issue 8, 2007, Pages 959-968

  Leuenberger, David ^a,e   Andresen, Per Arne ^b   Gosert, Rainer ^a   Binggeli, Simone ^a   Ström, Erik H ^b   Bodaghi, Sohrab ^a   Rinaldo, Christine Hanssen ^c   Hirsch, Hans H ^a,d  

^a UNIVERSITY OF BASEL   (Switzerland)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e Kantonsspital Aarau ^*  (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGNOPROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN VP1; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN; AGNOPROTEIN, POLYOMAVIRUS; GAMMA INTERFERON; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS T ANTIGEN;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; BK VIRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; BIOPSY; BIOSYNTHESIS; BLOOD; CELLULAR IMMUNITY; CYTOLOGY; EPITHELIUM CELL; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; KIDNEY DISEASE; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; METABOLISM; MONONUCLEAR CELL; VIROLOGY; VIRUS INFECTION; VIRUS REPLICATION;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL, TUMOR; BIOPSY; BK VIRUS; EPITHELIAL CELLS; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; KIDNEY TUBULES, PROXIMAL; LEUKOCYTES, MONONUCLEAR; POLYOMAVIRUS INFECTIONS; RECOMBINANT PROTEINS; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 35248853930     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00123-07     Document Type: Article

References (39)

1. Binggeli, S., A. Egli, M. Dickenmann, I. Binet, J. Steiger, and H. H. Hirsch. 2006. BKV replication and cellular immune responses in renal transplant recipients. Am. J. Transplant. 6:2218-2219.
2. Bratt, G., A. L. Hammarin, M. Grandien, B. G. Hedquist, I. Nennesmo, B. Sundelin, and S. Seregard. 1999. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS 13:1071-1075.
3. Brennan, D. C., I. Agha, D. L. Bohl, M. A. Schnitzler, K. L. Hardinger, M. Lockwood, S. Torrence, R. Schuessler, T. Roby, M. Gaudreault-Keener, and G. A. Storch. 2005. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am. J. Transplant. 5:582-594.
4. Butto, S., V. Fiorelli, A. Tripiciano, M. J. Ruiz-Alvarez, A. Scoglio, F. Ensoli, M. Ciccozzi, B. Collacchi, M. Sabbatucci, A. Cafaro, C. A. Guzman, A. Borsetti, A. Caputo, E. Vardas, M. Colvin, M. Lukwiya, G. Rezza, and B. Ensoli. 2003. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans. J. Infect. Dis. 188:1171-1180.
5. Comoli, P., S. Binggeli, F. Ginevri, and H. H. Hirsch. 2006. Polyomavirus-associated nephropathy: update on BK virus-specific immunity. Transpl. Infect. Dis. 8:86-94.
6. Corallini, A., G. Barbanti-Brodano, M. Portolani, P. G. Balboni, M. P. Grossi, L. Possati, C. Honorati, M. La Placa, A. Mazzoni, A. Caputo, U. Veronesi, S. Orefice, and G. Cardinali. 1976. Antibodies to BK virus structural and tumor antigens in human sera from normal persons and from patients with various diseases, including neoplasia. Infect. Immun. 13:1684-1691.
7. Drachenberg, C. B., J. C. Papadimitriou, R. Wali, C. L. Cubitt, and E. Ramos. 2003. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am. J. Transplant. 3:1383-1392.
8. Englert, C., X. Hou, S. Maheswaran, P. Bennett, C. Ngwu, G. G. Re, A. J. Garvin, M. R. Rosner, and D. A. Haber. 1995. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J. 14: 4662-4675.
9. Gardner, S. D., A. M. Field, D. V. Coleman, and B. Hulme. 1971. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet i:1253-1257.
10. Grinde, B., M. Gayorfar, and C. H. Rinaldo. 2007. Impact of a polyomavirus (BKV) infection on mRNA expression in human endothelial cells. Virus Res. 123:86-94.
11. Hangartner, L., R. M. Zinkernagel, and H. Hengartner. 2006. Antiviral antibody responses: the two extremes of a wide spectrum. Nat. Rev. Immunol. 6:231-243.
12. Hanssen Rinaldo, C., H. Hansen, and T. Traavik. 2005. Human endothelial cells allow passage of an archetypal BK virus (BKV) strain - a tool for cultivation and functional studies of natural BKV strains. Arch. Virol. 150: 1449-1458.
13. Heritage, J., P. M. Chesters, and D. J. McCance. 1981. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J. Med. Virol. 8:143-150.
14. Hey, A. W., J. I. Johnsen, B. Johansen, and T. Traavik. 1994. A two fusion partner system for raising antibodies against small immunogens expressed in bacteria. J. Immunol. Methods 173:149-156.
15. Hirsch, H. H. 2005. BK virus: opportunity makes a pathogen. Clin. Infect. Dis. 41:354-360.
16. Hirsch, H. H., D. C. Brennan, C. B. Drachenberg, F. Ginevri, J. Gordon, A. P. Limaye, M. J. Mihatsch, V. Nickeleit, E. Ramos, P. Randhawa, R. Shapiro, J. Steiger, M. Suthanthiran, and J. Trofe. 2005. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277-1286.
17. Hirsch, H. H., C. B. Drachenberg, J. Steiger, and E. Ramos. 2006. Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management. Adv. Exp. Med. Biol. 577:160-173.
18. Hirsch, H. H., W. Knowles, M. Dickenmann, J. Passweg, T. Klimkait, M. J. Mihatsch, and J. Steiger. 2002. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 347:488-496.
19. Hirsch, H. H., M. Mohaupt, and T. Klimkait. 2001. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J. Infect. Dis. 184:1494-1495. (Author reply, 184:1495-1496.)
20. Hirsch, H. H., and J. Steiger. 2003. Polyomavirus BK. Lancet Infect. Dis. 3:611-623.
21. Imperiale, M. J. 2001. The human polyomaviruses: an overview, p. 53-71. In K. Khalili and G. L. Stoner (ed.), Human polyomaviruses. Wiley-Liss, Hoboken, NJ.
22. Knowles, W. A. 2006. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv. Exp. Med. Biol. 577:19-45.
23. Knowles, W. A., P. Pipkin, N. Andrews, A. Vyse, P. Minor, D. W. Brown, and E. Miller. 2003. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J. Med. Virol. 71:115-123.
24. Low, J., H. D. Humes, M. Szczypka, and M. Imperiale. 2004. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 323:182-188.
25. Lundstig, A., and J. Dillner. 2006. Serological diagnosis of human polyomavirus infection. Adv. Exp. Med. Biol. 577:96-101.
26. Nomura, S., G. Khoury, and G. Jay. 1983. Subcellular localization of the simian virus 40 agnoprotein. J. Virol. 45:428-433.
27. Noss, G. 1987. Human polyoma virus type BK infection and T antibody response in renal transplant recipients. Zentbl. Bakteriol. Mikrobiol. Hyg. A 266:567-574.
28. Okada, Y., S. Endo, H. Takahashi, H. Sawa, T. Umemura, and K. Nagashima. 2001. Distribution and function of JCV agnoprotein. J. Neurovirol. 7:302-306.
29. Okada, Y., H. Sawa, S. Endo, Y. Orba, T. Umemura, H. Nishihara, A. C. Stan, S. Tanaka, H. Takahashi, and K. Nagashima. 2002. Expression of JC virus agnoprotein in progressive multifocal leukoencephalopathy brain. Acta Neuropathol. (Berlin) 104:130-136.
30. Patel, J., D. Galey, J. Jones, P. Ray, J. G. Woodward, A. Nath, and R. J. Mumper. 2006. HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant. Vaccine 24:3564-3573.
31. Ramos, E., C. B. Drachenberg, M. Portocarrero, R. Wali, D. K. Klassen, J. C. Fink, A. Farney, H. Hirsch, J. C. Papadimitriou, C. B. Cangro, M. R. Weir, and S. T. Bartlett. 2002. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program. Clin. Transpl. 2002:143-153.
32. Randhawa, P. S., G. Gupta, A. Vats, R. Shapiro, and R. P. Viscidi. 2006. Immunoglobulin G, A, andMresponses to BK virus in renal transplantation. Clin. Vaccine Immunol. 13:1057-1063.
33. Rezza, G., V. Fiorelli, M. Dorrucci, M. Ciccozzi, A. Tripiciano, A. Scoglio, B. Collacchi, M. Ruiz-Alvarez, C. Giannetto, A. Caputo, L. Tomasoni, F. Castelli, M. Sciandra, A. Sinicco, F. Ensoli, S. Butto, and B. Ensoli. 2005. The presence of anti-Tat antibodies is predictive of long-term nonprogression to AIDS or severe immunodeficiency: findings in a cohort of HIV-1 seroconverters. J. Infect. Dis. 191:1321-1324.
34. Rinaldo, C. H., M. R. Myhre, H. Alstad, O. Nilssen, and T. Traavik. 2003. Human polyomavirus BK (BKV) transiently transforms and persistently infects cultured osteosarcoma cells. Virus Res. 93:181-187.
35. Rinaldo, C. H., T. Traavik, and A. Hey. 1998. The agnogene of the human polyomavirus BK is expressed. J. Virol. 72:6233-6236.
36. Rodriguez, S. K., A. D. Sarr, O. Olorunnipa, S. J. Popper, A. Gueye-Ndiaye, I. Traore, M. C. Dia, S. Mboup, and P. J. Kanki. 2006. The absence of anti-Tat antibodies is associated with risk of disease progression in HIV-2 infection. J. Infect. Dis. 194:760-763.
37. Seif, I., G. Khoury, and R. Dhar. 1979. The genome of human papovavirus BKV. Cell 18:963-977.
38. Sester, M., U. Sester, B. C. Gartner, M. Girndt, A. Meyerhans, and H. Kohler. 2002. Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection. J. Am. Soc. Nephrol. 13:2577-2584.
39. Trofe, J., H. H. Hirsch, and E. Ramos. 2006. Polyomavirus- associated nephropathy: update of clinical management in kidney transplant patients. Transpl. Infect. Dis. 8:76-85.